Chronic chikungunya disease (CCD): clinical insights, immunopathogenesis and therapeutic perspectives - Aix-Marseille Université Accéder directement au contenu
Article Dans Une Revue QJM: An International Journal of Medicine Année : 2024

Chronic chikungunya disease (CCD): clinical insights, immunopathogenesis and therapeutic perspectives

Résumé

Abstract Chikungunya virus, an arthropod-borne pathogen is recognized by the World Health Organization as a top priority Emerging Infectious Disease and is ranked fourth in public health needs according to the Coalition for Epidemic Preparedness Innovations. Despite its substantial impact, as evidenced by an annual estimate of 120 274 disability-adjusted life years, our understanding of the chronic aspects of chikungunya disease remains limited. This review focuses on chronic chikungunya disease, emphasizing its clinical manifestations, immunopathogenesis, therapeutic options and disease burden.
Fichier non déposé

Dates et versions

hal-04543763 , version 1 (12-04-2024)

Identifiants

Citer

W Ng, K Amaral, E Javelle, S Mahalingam. Chronic chikungunya disease (CCD): clinical insights, immunopathogenesis and therapeutic perspectives. QJM: An International Journal of Medicine, 2024, pp.hcae028. ⟨10.1093/qjmed/hcae028⟩. ⟨hal-04543763⟩
13 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More